Have matters improved since May 6, 2014?
Published on May 6, 2014
In 2004, the Journal of Clinical Oncology published a study about chemotherapy’s success rates when looking at how many cancer patients were still alive after 5 years. It states: RESULTS:
The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA. CONCLUSION:
As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival.
To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required. You’d be hard pressed to find anything still being touted as your best shot at a cure with an average success rate of just over…
View original post 164 more words